Status:
UNKNOWN
Effect of Intravenous Dexmedetomidine on Patient Discomfort in Laparoscopic Cholecystectomy Under Spinal Anesthesia.
Lead Sponsor:
Theodor Bilharz Research Institute
Conditions:
Shoulder Pain
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
PHASE3
Brief Summary
Laparoscopic cholecystectomy (LC) has been routinely performed under general anesthesia despite the several disadvantages of general anesthesia compared to regional anesthesia. There are multiple rep...
Detailed Description
This is a prospective, randomized double blinded control study which will be conducted in department of anesthesia and surgical Intensive care unit at Theodor Bilharz Research Institute after approval...
Eligibility Criteria
Inclusion
- ASA 1-2.
- Patients undergoing elective laparoscopic Cholecystectomy with estimated pneumoperitoneum time of 60 to 90 min.
Exclusion
- Pregnancy.
- Lactating women.
- Any contraindication to spinal anesthesia e.g. Bleeding diathesis, infection at the puncture site, patient on anticoagulants or preexisting neurological deficits in lower extremities.
- Patients on α2-adrenergic receptors antagonists, calcium channel blockers, or angiotensin-converting enzyme inhibitors.
- Patients known allergic to bupivacaine or dexmedetomidine
Key Trial Info
Start Date :
November 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04115449
Start Date
November 15 2019
End Date
July 1 2021
Last Update
April 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Theodor Bilharz research institute
Cairo, Egypt, 02